In autumn 2008 the company lender to decide whether to give the credit to Avid, a small but promising venture capital, life sciences companies. When considering its proposal, Christie Barnes considers characteristics of the company and how they differ from conventional investments. At the same time, CEO and venture capitalist learn the true costs and benefits of taking credit, especially in the uncertain economic climate of the time. "Hide
by Matthew Rhodes-Kropf, Ann Leamon Source: Harvard Business School 15 pages. Publication Date: September 23, 2009. Prod. #: 810054-PDF-ENG